Cambridge, MA-based Quanterix is announcing today that Martin Madaus, the former CEO of Billerica, MA-based Millipore, has joined the startup’s board as executive chairman. Millipore, a giant supplier of diagnostics and lab equipment to biotech companies, was acquired by Germany-based Merck KGaA for about $7 billion in July. By joining Quanterix, he’s getting on board with a startup seeking to develop much more sensitive diagnostics that aims to spot disease earlier, and help doctors improve how they monitor the progression of disease. “This is a game changing technology,” Madaus said in a statement.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
